Jayalalithaa death probe commission censures Apollo for non-cooperation

CHENNAI: The commission inquiring into the death of former chief minister J Jayalalithaa has come down heavily on Apollo Hospitals, which treated the former chief minister during her 74-day stay at its flagship unit, taking exception to some of its doctors and technicians not honouring summons sent by the Commission.

Headed by retired Madras High Court judge A Arumughaswamy, the commission had recorded statements and allowed cross examinations of bureaucrats, politicians, medical practitioners and people perceived to have been close to Jayalalithaa to investigate whether the circumstances around her death indicate any foul play.

Significantly, the commission had recently summoned doctors from the All India Institute of Medical Sciences, and several doctors, nurses and technicians from the Apollo hospitals. Intimating the hospital about summons for medical equipment technicians, cardiologist Sai Sathish, a physiotherapist, and respiratory medicine expert Babu K Abraham.

In its note to Apollo Chairman Prathap Reddy, the commission said: “Take note that your hospital doctors who had given treatment to Hon’ble late chief minister J Jayalalithaa are asked to appear before this Comission on their respective dates in a phased manner. Even in the previous hearings, some of them have not appeared before the commission and have been condoned leniently. You are hereby directed to depute the doctors and Technician, to appear before this Commission without any technical objections…”

The Commission also made it a point to remind the hospitals about the revenue it had earned during the treatment to Jayalalithaa. “…remembering that your hospital has earned several crores of rupees in treatment charges. It is informed that if you fail to depute the doctors and technician, law will take its own course against you and your directors.

In a statement to ET, Apollo said: “To date ,36 witnesses from Hospital including senior doctors, nurses and paramedical staff have appeared and deposed before the commission. Summons were issued to 6 senior doctors with very short notice and they were unable to cancel appointments and surgical procedures scheduled much earlier. Therefore we requested the commission to provide notice of at least 7 days to enable the doctors to schedule their appointments and cause least inconvenience to their patients and not jeopardize patient care We are at all times willing to cooperate and will continue to cooperate with the learned commission.”

  • Related Posts

    CAHO Naa Patients Se Pyaar Hai

    Calcutta:  As Mishty Doi hit it off with over 2000 first rate delegates and healthcare’s quality crusaders from home and abroad, Patient safety resolve took center stage as never before…

    Ameera Shah, Prima Donna of Pathology, makes it to Powerful Healthcare Club NATHEALTH

    New Delhi:  She came, she saw and she conquered- This classic line aptly sums up the meteoric rise and shine of 44 year old Ameera Shah, Promoter &MD of Metropolis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs